effectiveness of tirzepatide Explained: The Future Weight Management New Dual Incretin Agonist for
Description
BloomMD provides administrative, technology, and support services only and does not practice medicine

After appropriate washout and placebo run-in periods, patients were randomized to receive pioglitazone 30 mg plus placebo or linagliptin 5 mg plus pioglitazone 30 mg, both once daily

Study after study has shown that older adults who carry a few extra pounds even enough to kick their BMIs into the overweight category tend to be healthier than those who are underweight

doi:10.1016/j.cjca.2011.07.007 Sinha A, Rahman H, Perera D

Overweight/obesity not only affects the glucose and lipid metabolism of patients but also exacerbates insulin resistance [4-6]

Furthermore, after 52 weeks of treatment, the Kansas City Cardiomyopathy Questionnaire clinical summary score (KCCQ-CSS) improved significantly among participants in the tirzepatide arm compared with those in the placebo arm (between-group difference = 6.9 [95% CI 3.310.6]
